Drug Shortages Back In US Congressional Spotlight

 
• By Laura Helbling

Drug shortages were a significant focus of legislative attention in the US before the COVID-19 pandemic, and Congress is not likely to drop the issue now that the public health emergency is winding down.

Out of stock
The Senate hearing raised several familiar themes that could end up in legislation. • Source: Shutterstock

More from Manufacturing

More from Compliance